However, not everyone converts synthetic forms efficiently, particularly those with higher metabolic stress, liver strain, or certain genetic variations including the MTHFR mutation
long-term safety and efficacy in humans have not been established
The lack of substantial overlap between these two predominant clusters suggests that the WD/LD-T group has a distinct pattern of ASV relative abundances in its microbiome compared to the other treatment groups
It reviews molecular identity, experimental models, analytical-quality principles, and published preclinical and human evidence
injury protocols require a different TB-4 dose
Like choline, it helps to reduce the amount of fat in the liver